Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2011 (2011), Article ID 594851, 7 pages
http://dx.doi.org/10.1155/2011/594851
Review Article

Improving Islet Engraftment by Gene Therapy

1Department of Surgery, University of British Columbia, Vancouver, BC, Canada V5Z 4E3
2Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada V5Z 4H4

Received 30 June 2011; Accepted 22 August 2011

Academic Editor: Diego Cantarovich

Copyright © 2011 Xiaojie Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. M. J. Shapiro, J. R. T. Lakey, E. A. Ryan et al., “Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen,” New England Journal of Medicine, vol. 343, no. 4, pp. 230–238, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. A. M. J. Shapiro, C. Ricordi, B. J. Hering et al., “International trial of the Edmonton protocol for islet transplantation,” New England Journal of Medicine, vol. 355, no. 13, pp. 1318–1330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. A. Fung, G. L. Warnock, Z. Ao et al., “The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim report,” Transplantation, vol. 84, no. 1, pp. 17–22, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. G. L. Warnock, Y. H. T. Liao, X. Wang et al., “An odyssey of islet transplantation for therapy of type 1 diabetes,” World Journal of Surgery, vol. 31, no. 8, pp. 1569–1576, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. G. L. Warnock, R. M. Meloche, D. Thompson et al., “Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus,” Archives of Surgery, vol. 140, no. 8, pp. 735–744, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. A. White, J. A. Shaw, and D. E. Sutherland, “Pancreas transplantation,” The Lancet, vol. 373, no. 9677, pp. 1808–1817, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. E. A. Ryan, B. W. Paty, P. A. Senior et al., “Five-year follow-up after clinical islet transplantation,” Diabetes, vol. 54, no. 7, pp. 2060–2069, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. G. C. Weir and S. Bonner-Weir, “Five of stages of evolving β-cell dysfunction during progression to diabetes,” Diabetes, vol. 53, supplement 3, pp. S16–S21, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Bonner-Weir, “Morphological evidence for pancreatic polarity of β-cell within islets of Langerhans,” Diabetes, vol. 37, no. 5, pp. 616–621, 1988. View at Google Scholar · View at Scopus
  10. L. Jansson and P. O. Carlsson, “Graft vascular function after transplantation of pancreatic islets,” Diabetologia, vol. 45, no. 6, pp. 749–763, 2002. View at Google Scholar · View at Scopus
  11. M. D. Menger, S. Jaeger, P. Walter, G. Feifel, F. Hammersen, and K. Messmer, “Angiogenesis and hemodynamics of microvasculature of transplanted islets of Langerhans,” Diabetes, vol. 38, supplement 1, pp. 199–201, 1989. View at Google Scholar · View at Scopus
  12. A. M. Davalli, L. Scaglia, D. H. Zangen, J. Hollister, S. Bonner-Weir, and G. C. Weir, “Vulnerability of islets in the immediate posttransplantation period: dynamic changes in structure and function,” Diabetes, vol. 45, no. 9, pp. 1161–1167, 1996. View at Google Scholar · View at Scopus
  13. M. Biarnés, M. Montolio, V. Nacher, M. Raurell, J. Soler, and E. Montanya, “β-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia,” Diabetes, vol. 51, no. 1, pp. 66–72, 2002. View at Google Scholar · View at Scopus
  14. P. D. Campbell, A. Weinberg, J. Chee et al., “Expression of pro- and anti-apoptotic molecules of the Bcl-2 family in human islets post-isolation,” Cell Transplantation. In press.
  15. S. Cabric, J. Sanchez, T. Lundgren et al., “Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation,” Diabetes, vol. 56, no. 8, pp. 2008–2015, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. J. D. Johnson, Z. Ao, P. Ao et al., “Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets,” Cell Transplantation, vol. 18, no. 8, pp. 833–845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Lau and P. O. Carlsson, “Low revascularization of human islets when experimentally transplanted into the liver,” Transplantation, vol. 87, no. 3, pp. 322–325, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Mattsson, L. Jansson, A. Nordin, A. Andersson, and P. O. Carlsson, “Evidence of functional impairment of syngeneically transplanted mouse pancreatic islets retrieved from the liver,” Diabetes, vol. 53, no. 4, pp. 948–954, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Cabric, J. Sanchez, T. Lundgren et al., “Islet surface heparinization prevents the instant blood-mediated inflammatory reaction in islet transplantation,” Diabetes, vol. 56, no. 8, pp. 2008–2015, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Kim, G. Kilimnik, C. Guo et al., “Computer-assisted large-scale visualization and quantification of pancreatic islet mass, size distribution and architecture,” Journal of Visualized Experiments, vol. 49, no. 49, p. 2471, 2011. View at Publisher · View at Google Scholar
  21. O. Cabrera, D. M. Berman, N. S. Kenyon, C. Ricordi, P. O. Berggren, and A. Caicedo, “The unique cytoarchitecture of human pancreatic islets has implications for islet cell function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2334–2339, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Nyqvist, M. Köhler, H. Wahlstedt, and P. O. Berggren, “Donor islet endothelial cells participate in formation of functional vessels within pancreatic islet grafts,” Diabetes, vol. 54, no. 8, pp. 2287–2293, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Mattsson, L. Jansson, and P. O. Carlsson, “Decreased vascular density in mouse pancreatic islets after transplantation,” Diabetes, vol. 51, no. 5, pp. 1362–1366, 2002. View at Google Scholar · View at Scopus
  24. P. O. Carlsson, F. Palm, and G. Mattsson, “Low revascularization of experimentally transplanted human pancreatic islets,” Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 12, pp. 5418–5423, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. J. L. Contreras, C. A. Smyth, C. Eckstein et al., “Peripheral mobilization of recipient bone marrow-derived endothelial progenitor cells enhances pancreatic islet revascularization and engraftment after intraportal transplantation,” Surgery, vol. 134, no. 2, pp. 390–398, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Lai, D. Schneider, A. Kidszun et al., “Vascular endothelial growth factor increases functional β-cell mass by improvement of angiogenesis of isolated human and murine pancreatic islets,” Transplantation, vol. 79, no. 11, pp. 1530–1536, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Zhang, A. Richter, J. Suriawinata et al., “Elevated vascular endothelial growth factor production in islets improves islet graft vascularization,” Diabetes, vol. 53, no. 4, pp. 963–970, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. G. D. Yancopoulos, S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash, “Vascular-specific growth factors and blood vessel formation,” Nature, vol. 407, no. 6801, pp. 242–248, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Ferrara, H. P. Gerber, and J. LeCouter, “The biology of VEGF and its receptors,” Nature Medicine, vol. 9, no. 6, pp. 669–676, 2003. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Ferrara, K. Carver-Moore, H. Chen et al., “Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene,” Nature, vol. 380, no. 6573, pp. 439–442, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Carmeliet, V. Ferreira, G. Breier et al., “Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele,” Nature, vol. 380, no. 6573, pp. 435–439, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Brissova, A. Shostak, M. Shiota et al., “Pancreatic islet production of vascular endothelial growth factor-A is essential for islet vascularization, revascularization, and function,” Diabetes, vol. 55, no. 11, pp. 2974–2985, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Lammert, G. Gu, M. McLaughlin et al., “Role of VEGF-A in vascularization of pancreatic islets,” Current Biology, vol. 13, no. 12, pp. 1070–1074, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Jabs, L. Franklin, M. B. Brenner et al., “Reduced insulin secretion and content in VEGF-A deficient mouse pancreatic islets,” Experimental and Clinical Endocrinology and Diabetes, vol. 116, supplement 1, pp. S46–S49, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Brissova, M. Fowler, P. Wiebe et al., “Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets,” Diabetes, vol. 53, no. 5, pp. 1318–1325, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Linn, K. Schneider, H. P. Hammes et al., “Angiogenic capacity of endothelial cells in islets of Langerhans,” FASEB Journal, vol. 17, no. 8, pp. 881–883, 2003. View at Google Scholar · View at Scopus
  37. B. Jiménez, O. V. Volpert, S. E. Crawford, M. Febbraio, R. L. Silverstein, and N. Bouck, “Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1,” Nature Medicine, vol. 6, no. 1, pp. 41–48, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. S. E. Crawford, V. Stellmach, J. E. Murphy-Ullrich et al., “Thrombospondin-1 is a major activator of TGF-β1 in vivo,” Cell, vol. 93, no. 7, pp. 1159–1170, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. H. Ishihara, H. Wang, L. R. Drewes, and C. B. Wollheim, “Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in β cells,” Journal of Clinical Investigation, vol. 104, no. 11, pp. 1621–1629, 1999. View at Google Scholar · View at Scopus
  40. J. C. Adams and J. Lawler, “The thrombospondins,” International Journal of Biochemistry and Cell Biology, vol. 36, no. 6, pp. 961–968, 2004. View at Publisher · View at Google Scholar · View at Scopus
  41. J. C. Rodríguez-Manzaneque, T. F. Lane, M. A. Ortega, R. O. Hynes, J. Lawler, and M. L. Iruela-Arispe, “Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 22, pp. 12485–12490, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Olerud, M. Johansson, J. Lawler, N. Welsh, and P. O. Carlsson, “Improved vascular engraftment and graft function after inhibition of the angiostatic factor thrombospondin-1 in mouse pancreatic islets,” Diabetes, vol. 57, no. 7, pp. 1870–1877, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Olerud, D. Mokhtari, M. Johansson et al., “Thrombospondin-1: an islet endothelial cell signal of importance for ß-cell function,” Diabetes, vol. 60, no. 7, pp. 1946–1954, 2011. View at Publisher · View at Google Scholar
  44. M. Holcik, H. Gibson, and R. G. Korneluk, “XIAP: apoptotic brake and promising therapeutic target,” Apoptosis, vol. 6, no. 4, pp. 253–261, 2001. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Hui, N. Khoury, X. Zhao et al., “Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets,” Diabetes, vol. 54, no. 2, pp. 424–433, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. J. A. Emamaullee, R. V. Rajotte, P. Liston et al., “XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes,” Diabetes, vol. 54, no. 9, pp. 2541–2548, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. J. D. Rivas-Carrillo, A. Soto-Gutierrez, N. Navarro-Alvarez et al., “Cell-permeable pentapeptide V5 inhibits apoptosis and enhances insulin secretion, allowing experimental single-donor islet transplantation in mice,” Diabetes, vol. 56, no. 5, pp. 1259–1267, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Rabinovitch, W. Sumoski, R. V. Rajotte, and G. L. Warnock, “Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture,” Journal of Clinical Endocrinology and Metabolism, vol. 71, no. 1, pp. 152–156, 1990. View at Google Scholar · View at Scopus
  49. J. O. Sandberg, D. L. Eizirik, S. Sandler, D. E. Tracey, and A. Andersson, “Treatment with an interleukin-1 receptor antagonist protein prolongs mouse islet allograft survival,” Diabetes, vol. 42, no. 12, pp. 1845–1851, 1993. View at Google Scholar · View at Scopus
  50. N. Giannoukakis, W. A. Rudert, S. C. Ghivizzani et al., “Adenoviral gene transfer of the interleukin-1 receptor antagonist protein to human islets prevents IL-lβ-induced β-cell impairment and activation of islet cell apoptosis in vitro,” Diabetes, vol. 48, no. 9, pp. 1730–1736, 1999. View at Publisher · View at Google Scholar · View at Scopus
  51. N. R. Barshes, S. Wyllie, and J. A. Goss, “Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts,” Journal of Leukocyte Biology, vol. 77, no. 5, pp. 587–597, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. F. Li and R. I. Mahato, “iNOS gene silencing prevents inflammatory cytokine-induced β-cell apoptosis,” Molecular Pharmaceutics, vol. 5, no. 3, pp. 407–417, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. N. M. Fiaschi-Taesch, D. M. Berman, B. M. Sicari et al., “Hepatocyte growth factor enhances engraftment and function of nonhuman primate islets,” Diabetes, vol. 57, no. 10, pp. 2745–2754, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. N. R. Barshes, S. Wyllie, and J. A. Goss, “Inflammation-mediated dysfunction and apoptosis in pancreatic islet transplantation: implications for intrahepatic grafts,” Journal of Leukocyte Biology, vol. 77, no. 5, pp. 587–597, 2005. View at Publisher · View at Google Scholar
  55. B. W. Lee, H. Y. Chae, T. T. N. Tuyen et al., “A comparison of non-viral vectors for gene delivery to pancreatic β-cells: delivering a hypoxia-inducible vascular endothelial growth factor gene to rat islets,” International Journal of Molecular Medicine, vol. 23, no. 6, pp. 757–762, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. H. A. Kim, B. W. Lee, D. Kang, J. H. Kim, S. H. Ihm, and M. Lee, “Delivery of hypoxia-inducible VEGF gene to rat islets using polyethylenimine,” Journal of Drug Targeting, vol. 17, no. 1, pp. 1–9, 2009. View at Publisher · View at Google Scholar · View at Scopus